Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma.

Abstract

BACKGROUND:

Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross-complementing gene-1 (ERCC1) are related to DNA synthesis and repair and essential in this regard. However, apart from the therapeutic benefit, their prognostic implication is controversial.

METHODS:

In this retrospective study, paraffin-embedded tissue from 51 cases of pancreatic cancer and 29 cases of cholangiocarcinoma were evaluated for RRM1 and ERCC1 expression by immunohistochemical technique along with 18 control pancreatic and biliary tissues. The semiquantitatively H score was calculated based on stain distribution and stain intensities.

RESULTS:

Both RRM1 and ERCC1 expression were high in tumor epithelium than in controls (RRM1: the difference was statistically significant in cholangiocarcinoma (P = 0.008); ERCC1: the difference was statistically significant both in pancreatic and cholangiocarcinoma (P < 0.05)]. However, no correlation was noted between RRM1 and ERCC1-low and high tumors with histological markers of prognosis and overall survival in these patients.

CONCLUSIONS:

The present study adds further evidence against the controversy that if RRM1 and ERCC1 expression in pancreatic and biliary carcinomas have any prognostic significance apart from their proven therapeutic benefits in these tumors.

• Authors: Khushbu Khetan, Ranjit K Sahoo, Vandana Baloda, Shalimar, Sreenivas Vishnubhatla, Anoop Saraya, Nihar Ranjan Dash, Atul Sharma, Siddhartha DattaGupta, Prasenjit Das
• Journal: Indian journal of pathology & microbiology (Indian J Pathol Microbiol) Vol. 64 Issue Supplement Pg. S160-S165 (Jun 2021) ISSN: 0974-5130 [Electronic] India
• PMID: 34135160 (Publication Type: Journal Article)

Chemical References

• Biomarkers, Tumor
• DNA-Binding Proteins
• RRM1 protein, human
• Ribonucleoside Diphosphate Reductase
• ERCC1 protein, human
• Endonucleases

Topics

• Adult
• Aged
• Biomarkers, Tumor
• Cholangiocarcinoma (genetics, physiopathology)
• DNA-Binding Proteins (genetics)
• Endonucleases (genetics)
• Female
• Humans
• Immunohistochemistry
• Male
• Middle Aged
• Pancreatic Neoplasms (genetics, physiopathology)
• Paraffin Embedding
• Prognosis
• Retrospective Studies
• Ribonucleoside Diphosphate Reductase (genetics)
• Pancreatic Neoplasms